Elsevier

Advances in Radiation Oncology

Volume 5, Issue 4, July–August 2020, Pages 589-594
Advances in Radiation Oncology

Brief Opinion
Palliative Radiation Therapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits

https://doi.org/10.1016/j.adro.2020.04.001Get rights and content
Under a Creative Commons license
open access

Abstract

Palliation of metastatic disease compromises a significant portion of radiation treatments in the United States. These patients present a unique challenge in resource-limited settings, as expeditious treatment is often required to prevent serious morbidity. In order to reduce the risk of infection with severe acute respiratory syndrome coronavirus-2 and maximize the benefit to patients, we present evidence-based recommendations for radiation in patients with oncologic emergencies. Radiation oncologists with expertise in the treatment of metastatic disease at a high-volume comprehensive cancer center reviewed the available evidence and recommended best practices for the treatment of common oncologic emergencies, with attention to balancing the risk of infection with severe acute respiratory syndrome coronavirus-2 and the potential morbidity of delaying treatment. Many prospective trials and national guidelines support the use of abbreviated courses of radiotherapy for patients with oncologic emergencies. As such, in the setting of the current coronavirus disease 2019 pandemic, the use of hypofractionated radiation therapy for patients requiring palliation for oncologic emergencies achieves desirable functional outcomes without compromising care.

Cited by (0)

Sources of support: National Institutes of Health/National Cancer Institute (P30-CA008748).

Disclosures: none.

1

D.Y., A.J.X., C.J.T., and T.J.Y. contributed equally to this article.